CareLit · DOI-Nachweis · Pneumologie
Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF
DOI 10.1055/s-0036-1572069
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Milger, N Kneidinger, C Neurohr, F Reichenberger, J Behr
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Rationale: The IPF treatments pirfenidone and nintedanib have overlapping adverse effect profiles with gastrointestinal disorders among the most frequent reasons for drug discontinuation. Further, intraindividual response to pirfenidone treatment varies. It is unknown whether nintedanib can be tolerated and efficacious in patients displaying intolerability or inefficacy of pirfenidone treatment. Objectives: To asses…
Zitieren
Zitierempfehlung
K Milger, N Kneidinger, C Neurohr, F Reichenberger, J Behr (2016) Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF. Pneumologie (02). https://doi.org/10.1055/s-0036-1572069
Mit CareLit weiterarbeiten